Form 8-K - Current report:
SEC Accession No. 0001437749-24-038599
Filing Date
2024-12-31
Accepted
2024-12-31 16:07:09
Documents
14
Period of Report
2024-12-31
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K vxrt20241231_8k.htm   iXBRL 8-K 27950
  Complete submission text file 0001437749-24-038599.txt   160928

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA vxrt-20241231.xsd EX-101.SCH 3410
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vxrt-20241231_def.xml EX-101.DEF 11425
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vxrt-20241231_lab.xml EX-101.LAB 15311
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vxrt-20241231_pre.xml EX-101.PRE 11585
16 EXTRACTED XBRL INSTANCE DOCUMENT vxrt20241231_8k_htm.xml XML 2830
Mailing Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35285 | Film No.: 241593069
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)